Pediatrix Medical Group, Inc. MD
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.51% | -2.25% | -4.92% | -4.21% | -3.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.51% | -2.25% | -4.92% | -4.21% | -3.08% |
| Cost of Revenue | -1.99% | -5.71% | -8.88% | -9.74% | -7.40% |
| Gross Profit | 8.26% | 9.07% | 8.66% | 16.22% | 13.35% |
| SG&A Expenses | 5.10% | 2.37% | 0.99% | 4.70% | 3.85% |
| Depreciation & Amortization | -2.90% | -17.01% | -32.27% | -32.97% | -36.39% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.03% | -4.80% | -8.01% | -8.38% | -6.61% |
| Operating Income | 13.01% | 20.68% | 25.81% | 42.45% | 39.69% |
| Income Before Tax | 59.73% | 380.22% | 313.57% | 174.64% | 152.86% |
| Income Tax Expenses | 62.16% | 3,999.30% | 2,346.65% | 313.28% | 297.71% |
| Earnings from Continuing Operations | 59.03% | 311.52% | 266.94% | 163.89% | 143.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.03% | 311.52% | 266.94% | 163.89% | 143.64% |
| EBIT | 13.01% | 20.68% | 25.81% | 42.45% | 39.69% |
| EBITDA | 11.41% | 16.12% | 17.14% | 29.41% | 24.71% |
| EPS Basic | 62.81% | 307.28% | 263.20% | 162.56% | 142.82% |
| Normalized Basic EPS | 24.96% | 34.40% | 43.15% | 64.18% | 57.62% |
| EPS Diluted | 62.18% | 303.41% | 261.10% | 161.92% | 142.42% |
| Normalized Diluted EPS | 23.83% | 33.47% | 42.37% | 63.36% | 56.91% |
| Average Basic Shares Outstanding | -2.64% | -0.63% | 0.90% | 1.88% | 2.08% |
| Average Diluted Shares Outstanding | -1.80% | 0.06% | 1.40% | 2.38% | 2.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |